Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy

Author:

Dorward Jienchi12ORCID,Sookrajh Yukteshwar3,Lessells Richard24,Bulo Elliot3,Bodley Nicola2,Singh Lavanya4,Moodley Pravikrishnen5,Samsunder Natasha2,Drain Paul K.678,Hayward Gail1,Butler Christopher C.1,Garrett Nigel29

Affiliation:

1. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom;

2. Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa;

3. eThekwini Municipality Health Unit, Durban, South Africa;

4. KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa;

5. Department of Virology, University of KwaZulu-Natal and National Health Laboratory Service, Inkosi Albert Luthuli Central Hospital, KwaZulu-Natal, South Africa;

6. Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA;

7. Department of Medicine, School of Medicine, University of Washington, Seattle, WA;

8. Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA; and

9. Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.

Funder

Wellcome Trust

Global Challenges Research Fund

Africa Oxford Initiative

National Institute for Health and Care Research

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3